Chewed to Bits

Some scientists are turning to CRISPR-Cas3 rather than the more commonly known CRISPR-Cas9 gene-editing tool to tackle antibiotic resistance, according to Gizmodo.

CRISPR-Cas9 has caught numerous researchers' imagination as it can make relatively precise cuts in the genome. But CRISPR-Cas3 is a little less precise. "If CRISPR-Cas9 is a genetic scalpel, Cas3 is a chainsaw," Gizmodo writes.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.